Ethambutol 400 mg Tablets Միացյալ Թագավորություն - անգլերեն - myHealthbox

ethambutol 400 mg tablets

peckforton pharmaceuticals ltd - ethambutol hydrochloride - film-coated tablet - 400 mg - antimycobacterial - it is indicated for the primary treatment and re-treatment of tuberculosis and for prophylaxis in cases of inactive tuberculosis or large-tuberculinpositive reaction

Ethambutol 100 mg Tablets Միացյալ Թագավորություն - անգլերեն - myHealthbox

ethambutol 100 mg tablets

peckforton pharmaceuticals ltd - ethambutol hydrochloride - film-coated tablet - 100 mg - antimycobacterial - it is used for the primary treatment and re-treatment of tuberculosis and for prophylaxis in cases of inactive tuberculosis or large-tuberculinpositive reaction.

Lax-Tab Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

lax-tab

aft pharmaceuticals ltd - bisacodyl 5mg - enteric coated tablet - 5 mg - active: bisacodyl 5mg excipient: calcium carbonate colloidal silicon dioxide gelatin lactose monohydrate macrogol 6000 magnesium stearate methacrylic acid copolymer microcrystalline cellulose povidone   purified talc   quinoline yellow silicon sodium starch glycolate starch sucrose

pdp-Pyrazinamide Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

pdp-pyrazinamide

aft pharmaceuticals ltd - pyrazinamide 500mg;   - tablet - 500 mg - active: pyrazinamide 500mg   excipient: colloidal silicon dioxide microcrystalline cellulose pregelatinised maize starch starch stearic acid - pdp-pyrazinamide is indicated in patients with active tuberculosis caused by mycobacterium tuberculosis. pdp-pyrazinamide is not active against the atypical mycobacteria. pdp-pyrazinamide should be given only in combination with other effective anti-tuberculous agents.

MENTAX CREAM Իսրայել - անգլերեն - Ministry of Health

mentax cream

padagis israel pharmaceuticals ltd, israel - butenafine hydrochloride - cream - butenafine hydrochloride 1 % - butenafine - butenafine - interdigital tinea pedis, tinea coporis, tinea cruris . (treatment in tinea coporis and tinea cruris is limited to up to 4 weeks).

NORPROLAC 0.025 MG Իսրայել - անգլերեն - Ministry of Health

norprolac 0.025 mg

ferring pharmaceuticals ltd - quinagolide as hydrochloride - tablets - quinagolide as hydrochloride 0.025 mg - quinagolide - quinagolide - second line treatment of hyperprolactinaemia (idiopathic or due to prolactin secreting micro- or macroadenoma) and its clinical manifestation (galactorrhoea, oligomenorrhea, infertility, reduced libido).

NORPROLAC 0.05 MG Իսրայել - անգլերեն - Ministry of Health

norprolac 0.05 mg

ferring pharmaceuticals ltd - quinagolide as hydrochloride - tablets - quinagolide as hydrochloride 0.05 mg - quinagolide - quinagolide - second line treatment of hyperprolactinaemia (idiopathic or due to prolactin secreting micro- or macroadenoma) and its clinical manifestation (galactorrhoea, oligomenorrhea, infertility, reduced libido).

NORPROLAC 0.075 MG TABLETS Իսրայել - անգլերեն - Ministry of Health

norprolac 0.075 mg tablets

ferring pharmaceuticals ltd - quinagolide as hydrochloride - tablets - quinagolide as hydrochloride 0.075 mg - quinagolide - quinagolide - second line treatment of hyperprolactinaemia (idiopathic or due to prolactin secreting micro- or macroadenoma) and its clinical manifestation (galactorrhoea, oligomenorrhea, infertility, reduced libido).

NORPROLAC 0.15 MG TABLETS Իսրայել - անգլերեն - Ministry of Health

norprolac 0.15 mg tablets

ferring pharmaceuticals ltd - quinagolide as hydrochloride - tablets - quinagolide as hydrochloride 0.15 mg - quinagolide - quinagolide - second line treatment of hyperprolactinaemia (idiopathic or due to prolactin secreting micro- or macroadenoma) and its clinical manifestation (galactorrhoea, oligomenorrhea, infertility, reduced libido).

MIFEGYNE Իսրայել - անգլերեն - Ministry of Health

mifegyne

a. lapidot pharmaceuticals, ltd - mifepristone - tablets - mifepristone 200 mg - mifepristone - mifepristone - medical termination of developing intra-uterine pregnancy.- in sequential use with a prostaglandin analogue up to 63 days of amenorrhea.- softening and dilatation of the cervix uteri prior to surgical termination of pregnancy during the first trimester.- preparation for the action of prostaglandin analogues in the termination of pregnancy for medical reasons (beyond the first trimester).- labour induction in foetal death in utero.in patients where prostaglandin or oxytocin cannot be use.